Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.082 | 0.7 |
mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.082 | 0.7 |
mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.071 | 0.7 |
mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |